GSK sales switch
July 27, 2010
GLAXOSMITHKLINE has
announced that its US sales staff
will no longer be evaluated or paid
bonuses related to their
achievement of sales targets.
Beginning next year, GSK will
instead base bonuses primarily on
the service delivered to customers
as determined by client feedback,
as well as to a sales professional’s
“adherence to the company values
of transparency, integrity, respect
and patient-focus”.
“Physicians have been telling us
they want to see fewer sales
professionals, and those they do
see need to provide greater value in
helping improve patient health,”
said GSK President, North America
Pharmaceuticals, Deirdre Connelly.
The above article was sent to subscribers in Pharmacy Daily's issue from 27 Jul 10To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 27 Jul 10